Literature DB >> 23344108

Evaluation of factors associated with achieving glycemic control in a pharmacist-managed diabetes clinic.

Matthew D Kostoff1, Melanie L Boros, John M Moorman, Lawrence A Frazee.   

Abstract

The aim of this study was to identify factors that are associated with patients achieving goal A1c after 6 months in a pharmacist-managed diabetes clinic. This study is a descriptive, retrospective chart review of patients with type 2 diabetes enrolled in a pharmacist-managed diabetes clinic. The primary endpoint was the odds of each identified factor being associated with achievement of goal A1c after 6 months of enrollment. The factors were also evaluated within 2 subgroups: those with a baseline A1c >7% and those with a baseline A1c >9%. Of 112 patients enrolled, 58 were included in the analysis. There was a positive association with reaching goal for patients who had <1 failure to show (FTS) to office visits in 6 months [odds ratio (OR) 8.10, 95% confidence interval (CI) 1.47-58.65], had canceled or FTS to <50% of office visits (OR 10.0, 95% CI 1.8-72.79), and brought >75% of blood glucose logs to their office visits (OR 7.36, 95% CI 1.87-30.88). There was a negative association with reaching the goal for patients with documented social worker involvement (OR 0.22, 95% CI 0.04-0.99) and noninsulin or insulin dose increases at >50% of office visits (OR 0.10, 95% CI 0.01-0.55). Overall, this analysis found that patients who had <1 FTS, had canceled or FTS to <50% of office visits, or who brought >75% logs to office visits were more likely to achieve goal A1c, whereas patients with social work assistance or dose increases at >50% of office visits were less likely to reach goal A1c.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23344108     DOI: 10.1097/MJT.0b013e31826fc47e

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  3 in total

1.  Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients.

Authors:  Abdel-Hameed I Ebid; Mohamed A Mobarez; Ramadan A Ramadan; Mohamed A Mahmoud
Journal:  Hosp Pharm       Date:  2020-11-25

2.  Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.

Authors:  Yves Michiels; Olivier Bugnon; Annie Chicoye; Sylvie Dejager; Christine Moisan; François-André Allaert; Catherine Hunault; Laura Romengas; Hubert Méchin; Bruno Vergès
Journal:  Adv Ther       Date:  2019-05-02       Impact factor: 3.845

3.  A Community Pharmacy-Based Intervention in the Matrix of Type 2 Diabetes Mellitus Outcomes (CPBI-T2DM): A Cluster Randomized Controlled Trial.

Authors:  Hassan Farag Mohamed; Magdy Mohamed Allam; Noha Alaa Hamdy; Ramy Mohamed Ghazy; Rana Hassan Emara
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.